Self-administered prescriptions of oral steroids and antibiotics in chronic obstructive pulmonary disease: are we doing more harm than good?

Abstract

Patients with chronic obstructive pulmonary disease (COPD) are often given a prescription for a short course of oral steroids and antibiotics for self-administration during an acute exacerbation. The main objective of this study was to determine the impact of such prescriptions on medical care utilization, and steroids and antibiotics intake. This retrospective cohort study included patients with moderate to severe COPD participating in a self-management programme. We compared the number of unplanned medical visits (including hospitalizations) and the utilization of systemic steroids (number of short courses, number of days on treatment) and antibiotics (number of treatments) over a period of six months following registration to the programme in patients who received such a prescription and those who did not. Data were collected from hospital and community pharmacy files. A total of 89 patients were included; 46 received a self-administered prescription. During the study period, we found no difference between the two groups in the number of unplanned medical visits. However, we observed small but significant differences in the number of short courses of Prednisone (P = 0.018) and antibiotics (P = 0.006). This translated in an important difference in the number of days on steroids over the same period (`Prescription' group: 26; controls: 8; P = 0.005). Self-administered prescriptions may increase steroids and antibiotics utilization in patients with moderate to severe COPD, without reducing the number of unplanned medical visits. Chronic Respiratory Disease 2007; 4: 143—147

Keywords

antibiotics COPD exacerbation health care utilization self-management steroids

References

Donaldson GC , Wedzicha JA COPD exacerbations. 1: Epidemiology. Thorax 2006; 61: 164—68.

Pauwels R. , Calverley P. , Buist AS et al. COPD exacerbations: the importance of a standard definition . Respir Med 2004; 98: 99—107.

O'Donnell DE , Aaron S. , Bourbeau J. et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2003. Can Respir J 2003; 10(Suppl A): 11A—65A.

Seemungal TA , Donaldson GC , Paul EA et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418—22.

Donaldson GC , Seemungal TA , Bhowmik A. et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847—52.

Soler-Cataluna JJ , Martinez-Garcia MA , Roman SP et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925—31.

Sapey E. , Stockley RA COPD exacerbations. 2: Aetiology. Thorax 2006 ; 61: 250—58.

Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest 2000; 117: 380S—385S.

Wilkinson TM , Donaldson GC , Hurst JR et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169: 1298—303.

10.

Bourbeau J. , Julien M. , Maltais F. et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003; 163: 585—91.

11.

Balter MS , La Forge J. , Low DE et al. Canadian guidelines for the management of acute exacerbations of chronic bronchitis: executive summary. Can Respir J 2003; 10: 248—58.

12.

Pauwels RA , Buist AS , Calverley PM et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256—76.

13.

Wood-Baker RR , Gibson PG , Hannay M. et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005; CD001288.

14.

Aaron SD , Vandemheen KL , Hebert P. et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003; 348: 2618—25.

15.

Niewoehner DE , Erbland ML , Deupree RH et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999; 340: 1941—47.

16.

Anthonisen NR , Manfreda J. , Warren CP et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196—204.

17.

Miravitlles M. , Ferrer M. , Pont A. et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004; 59: 387—95.

18.

Kessler R. , Stahl E. , Vogelmeier C. et al. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest 2006; 130: 133—42.

19.

Taylor SJ , Candy B. , Bryar RM et al. Effectiveness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence. Br Med J 2005; 331: 485—89.